Serial Number
99351616
Owner
SENOTHERAPEUTIX, Inc.Attorney
Jared L. DuJackFiling Date
Aug 22, 2025
PERSEUS SENOLYTIX Trademark
Serial Number: 99351616
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Correspondence Address
Jared L. DuJack Schmeiser, Olsen & Watts, LLP
22 Century Hill Drive, Suite 302
Latham, NY 12110
United States
Trademark Details
Filing Date
August 22, 2025
Registration Date
Not Registered
Goods & Services
Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Synthesized peptides for use in cancer and age-related diseases; Synthesized peptides for use in skin conditions; Synthesized anti-cancer peptides; Synthesized anti-aging peptides; Synthesized peptides for use in prevention of radiation damage; Synthesized peptides for use in treatment of radiation damage; Synthesized peptides for use in prevention of radiation related diseases; Synthesized peptides for use in treatment of radiation related diseases
Medical research services; Medical research services, namely, anti-cancer and anti-aging medical research services; Medical research services in the field of prevention and treatment of cancer and age-related disorders; Medical research laboratory services; Medical research laboratory services related to cancer; Medical research laboratory services related to biologic age; Medical research laboratory services related to biological age scoring; Medical research laboratory services related to determining a number or percentage of senescent cells; Non-invasive pathological testing for medical research purposes; Non-invasive pathological testing related to cancer for medical research purposes; Non-invasive pathological testing related to biologic age for medical research purposes; Non-invasive pathological testing related to biological age scoring for medical research purposes; Non-invasive pathological testing related to determining a number or percentage of senescent cells for medical research purposes; Medical research on the prevention of cancer; Medical research on the treatment of cancer; Medical research on the prevention of radiation damage; Medical research on the treatment of radiation damage; Medical research on the prevention of radiation related diseases; Medical research on the treatment of radiation related diseases; Medical research in the field of anti-cancer; Medical research in the field of anti-aging; Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of cancer and age-related diseases; Testing, inspection, research, and development of pharmaceutical preparations for cancer therapy and age therapy; Consulting services in the fields of biotechnology, and pharmaceutical research and development
Medical services in the field of anti-cancer therapy; Medical services in the field of anti-cancer services; Medical services in the field of anti-aging therapy; Medical services in the field of anti-aging medical services; Consulting services in the fields of medical testing and medical diagnostic services; Medical testing services, namely, biologic age scoring; Medical testing services, namely, statistical scoring to determine a biologic age score of a patient; Medical services; Medical services, namely, anti-cancer and anti-aging services; Medical services, namely, prevention and treatment of cancer and age-related disorders; Medical advisory services; Medical advisory services in the field of anti-cancer and anti-aging services; Medical advisory services in the field of prevention and treatment of cancer and age-related disorders; Medical testing services; Medical testing services, namely, medical testing for anti-cancer and anti-aging; Medical testing services, namely, medical testing for the prevention and treatment of cancer and age-related disorders; Medical services in the field of anti-cancer and anti-aging; Medical services in the field of senescent cells; Medical services in the field of cancer and age-related disorders; Biopsy services in the nature of medical testing services; Biopsy services in the nature of medical testing services related to cancer; Biopsy services in the nature of medical testing services related to biologic age; Biopsy services in the nature of medical testing services related to biological age scoring; Biopsy services in the nature of medical testing services related to determining a number or percentage of senescent cells; Medical treatment of cancer; Medical treatment of radiation damage; Medical treatment of radiation related diseases